METHOD FOR PREDICTING THE TYPE OF PARTURITION ABNORMALITIES

METHOD FOR PREDICTING THE TYPE OF PARTURITION ABNORMALITIES

FIELD: medicine, laboratory diagnostics. ^ SUBSTANCE: one should detect erythrocytic osmoresistance in the presence of beta-adrenoblocator - 1-(1-isopropylamino)-3-(1-naphthalenyl-oxy)-2-propanol hydrochloride and at its value of osmoresistance being below 65 c.u. it is necessary to predict the deve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DLUSSKAJA IRINA GEORGIEVNA, BRAGINSKAJA SVETLANA GENRIKHOVNA, STRJUK RAISA IVANOVNA, SMOL'NOVA TAT'JANA JUR'EVNA, MIKHSIN SVETLANA VIKTOROVNA, ADAMJAN LEJLA VLADIMIROVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
PHYSICS
TESTING
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine, laboratory diagnostics. ^ SUBSTANCE: one should detect erythrocytic osmoresistance in the presence of beta-adrenoblocator - 1-(1-isopropylamino)-3-(1-naphthalenyl-oxy)-2-propanol hydrochloride and at its value of osmoresistance being below 65 c.u. it is necessary to predict the development of hypotonic uterine dysfunctions at the stage of preliminary period and the first stage of parturition, and at the value of 80 c.u. and more - hypertonic uterine dysfunctions as pathological preliminary period, dystocia of uterine cervix and discoordinated parturition activity. The innovation enables to predict abnormalities of parturition at preclinical stage. ^ EFFECT: higher accuracy and efficiency of prediction. ^ 4 ex, 2 tbl